August 16, 2017 — Carestream Health recently introduced new MR (magnetic resonance) Brain Perfusion and MR Brain Diffusion modules that enable radiologists to read these imaging studies from a Carestream Vue PACS (picture archiving and communication system) diagnostic viewer. The company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for use in the United States, and these new tools also have been approved for use in Europe and other countries across the globe.
According to the company, it is one of the first suppliers to support reading of both types of studies from the diagnostic viewer; other companies require viewing on dedicated workstations with 3-D post-processing software, which Carestream says limits access and can delay diagnosis and treatment.
The MR Perfusion and MR Diffusion modules successfully completed clinical evaluation at a prominent French hospital.
“The Carestream software was simple to use and Carestream’s modules showed better consistency of perfusion and diffusion maps and results than our existing software. This new software will be very useful in making clinical decisions for treating acute stroke and lesions,” said Daniel Reizine, M.D., neuroradiology, Hospital Lariboisière, Assistance Publique Hôpitaux de Paris, University Hospital of Île-de-France.
Carestream’s CT (computed tomography) Brain Perfusion module provides interactive tools for analyzing tissue blood flow, tissue blood volume and capillary permeability. Blood perfusion parameters are automatically calculated and displayed as a set of user-friendly maps and tables that summarize the results.
The MR Brain Perfusion module provides interactive tools for analyzing tissue blood flow, tissue blood volume and capillary permeability and delivers automatic generation of perfusion maps and a table of quantitative data that can be inserted into the radiology report.
Both CT and MR perfusion modules provide automatic identification of arterial input function, venous output function and brain centerline with the ability to edit and select additional vessels. Motion correction and ROI tools are available for improving diagnostic confidence.
Perfusion maps and quantitative measurements can be included automatically in the Vue Reporting module so this diagnostic information can be readily available to clinicians and referring physicians.
Carestream’s MR Brain Diffusion module provides interactive tools to ease analysis and comparison of MR diffusion-weighted images (DWI) and MR diffusion tensor imaging. The module is used to visualize local water diffusion properties from the analysis of diffusion-weighted MR data. Automatic display of DWI images as well as calculation of ADC maps can improve efficiency and diagnostic confidence.
The company’s Vue PACS lesion management tool enhances assessment of oncology patients with quantitative measurements, bookmarking and comparisons over time to aid oncologists who are making diagnostic and treatment decisions. It accepts prior exam results as baseline images from third-party PACS and from numerous modalities.
For more information: www.carestream.com